This is consistent with our observation of higher expression of neural markers, and of GPR158 and CCND1 in miR-449alow tumours developing from allografted Pten/p53 cells and from Rb/p53 cells treated with miR-449a antagomir (Fig. 6). The gene discussed is GPR158; the disease is neoplasm.